Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Howard Hughes Medical Institute, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Structure. 2013 Jan 8;21(1):42-53. doi: 10.1016/j.str.2012.10.013. Epub 2012 Nov 29.
Little is known about molecular recognition of acetylated N termini, despite prevalence of this modification among eukaryotic cytosolic proteins. We report that the family of human DCN-like (DCNL) co-E3s, which promote ligation of the ubiquitin-like protein NEDD8 to cullin targets, recognizes acetylated N termini of the E2 enzymes UBC12 and UBE2F. Systematic biochemical and biophysical analyses reveal 40- and 10-fold variations in affinities among different DCNL-cullin and DCNL-E2 complexes, contributing to varying efficiencies of different NEDD8 ligation cascades. Structures of DCNL2 and DCNL3 complexes with N-terminally acetylated peptides from UBC12 and UBE2F illuminate a common mechanism by which DCNL proteins recognize N-terminally acetylated E2s and how selectivity for interactions dependent on N-acetyl-methionine are established through side chains recognizing distal residues. Distinct preferences of UBC12 and UBE2F peptides for inhibiting different DCNLs, including the oncogenic DCNL1 protein, suggest it may be possible to develop small molecules blocking specific N-acetyl-methionine-dependent protein interactions.
尽管这种修饰在真核细胞质蛋白中很常见,但人们对乙酰化 N 端的分子识别知之甚少。我们报告说,人类 DCN 样(DCNL)共 E3 家族,可促进泛素样蛋白 NEDD8 与连接酶靶标的连接,可识别 E2 酶 UBC12 和 UBE2F 的乙酰化 N 端。系统的生化和生物物理分析揭示了不同 DCNL-连接酶和 DCNL-E2 复合物之间亲和力的 40 倍和 10 倍变化,这导致了不同 NEDD8 连接级联的效率不同。DCNL2 和 DCNL3 与来自 UBC12 和 UBE2F 的 N 端乙酰化肽的复合物结构阐明了 DCNL 蛋白识别 N 端乙酰化 E2 的常见机制,以及如何通过识别远端残基的侧链来建立对依赖 N-乙酰甲硫氨酸的相互作用的选择性。UBC12 和 UBE2F 肽对不同 DCNL 的不同抑制偏好,包括致癌 DCNL1 蛋白,表明可能有可能开发出阻止特定 N-乙酰甲硫氨酸依赖性蛋白质相互作用的小分子。